Literature DB >> 15101558

Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma.

Evzen Krepela1, Jan Procházka, Xiaoyi Liul, Pavel Fiala, Zdenĕk Kinkor.   

Abstract

The intrinsic apoptosis apparatus plays a significant role in generating and amplifying cell death signals. In this study we examined whether there are differences in the expression of its components and in its functioning in non-small cell lung carcinoma (NSCLC) and the lung. We show that NSCLC cell lines express Apaf-1 and procaspase-9 and -3 proteins and that the expression of Apaf-1 and procaspase-3, but not of procaspase-9 and -7, is frequently up-regulated in NSCLC tissues as compared to the lung. NSCLC tissues and lungs and some NSCLC cell lines expressed also caspase-9S(b) and displayed a high caspase-9S(b)/procaspase-9 expression ratio. Procaspase-3 from NSCLCs and lungs was readily processed to caspase-3 by granzyme B or caspase-8, and the granzyme B-generated caspase-3-like activity was significantly higher in tumor tissues and cells than in lungs. By contrast, cytochrome c plus dATP could induce a significant increase of caspase-3-like activity in cytosol only in some NSCLC cell lines and in subsets of studied NSCLC tissues and lungs, while procaspase-3 and -7 were detectably processed only in NSCLC tissues which showed a high (cytochrome c+dATP)-induced caspase-3-like activity. Taken together, the present study provides evidence that the expression of Apaf-1 and procaspase-3 is up-regulated in NSCLCs and indicates that the tumors have a capability to suppress the apoptosome-driven caspase activation in their cytosol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15101558     DOI: 10.1515/BC.2004.034

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  23 in total

1.  Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

Authors:  Danny C Hsu; Howard S Roth; Diana C West; Rachel C Botham; Chris J Novotny; Steven C Schmid; Paul J Hergenrother
Journal:  ACS Comb Sci       Date:  2011-10-28       Impact factor: 3.784

2.  Apoptosis-Related Single Nucleotide Polymorphisms and the Risk of Non-Small Cell Lung Cancer in Women.

Authors:  Anand Pathak; Angela S Wenzlaff; Paula L Hyland; Michele L Cote; Greg R Keele; Susan Land; Matthew L Boulton; Ann G Schwartz
Journal:  J Cancer Ther Res       Date:  2014

3.  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.

Authors:  Howard S Roth; Rachel C Botham; Steven C Schmid; Timothy M Fan; Levent Dirikolu; Paul J Hergenrother
Journal:  J Med Chem       Date:  2015-04-20       Impact factor: 7.446

4.  Differential effects of procaspase-3 activating compounds in the induction of cancer cell death.

Authors:  Diana C West; Yan Qin; Quinn P Peterson; Diana L Thomas; Rahul Palchaudhuri; Karen C Morrison; Pamela W Lucas; Amy E Palmer; Timothy M Fan; Paul J Hergenrother
Journal:  Mol Pharm       Date:  2012-04-27       Impact factor: 4.939

5.  Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs.

Authors:  Pamela W Lucas; Joanna M Schmit; Quinn P Peterson; Diana C West; Danny C Hsu; Chris J Novotny; Levent Dirikolu; Mona I Churchwell; Daniel R Doerge; Laura D Garrett; Paul J Hergenrother; Timothy M Fan
Journal:  Invest New Drugs       Date:  2010-05-25       Impact factor: 3.850

6.  PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition.

Authors:  Quinn P Peterson; David R Goode; Diana C West; Kara N Ramsey; Joy J Y Lee; Paul J Hergenrother
Journal:  J Mol Biol       Date:  2009-03-10       Impact factor: 5.469

7.  Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3.

Authors:  Quinn P Peterson; Danny C Hsu; David R Goode; Chris J Novotny; Ryan K Totten; Paul J Hergenrother
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

8.  A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts.

Authors:  Fangyang Wang; Lihui Wang; Yanfang Zhao; Yi Li; Guanfang Ping; Shu Xiao; Kang Chen; Wufu Zhu; Ping Gong; Jingyu Yang; Chunfu Wu
Journal:  Mol Oncol       Date:  2014-07-03       Impact factor: 6.603

9.  The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.

Authors:  Jessie Peh; Timothy M Fan; Kathryn L Wycislo; Howard S Roth; Paul J Hergenrother
Journal:  Mol Cancer Ther       Date:  2016-06-13       Impact factor: 6.261

10.  Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

Authors:  Howard S Roth; Paul J Hergenrother
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.